In conclusion, CLDN18 was upregulated in the tumor tissues as well as the PBMCs from HCC patients compared to the normal adjacent tissues and the PBMCs from healthy donors respectively. This evidence concerns the gene CLDN18 and hepatocellular carcinoma.